Proportion of participants who have a negative reverse transcription polymerase chain reaction (RT-PCR) result at baseline who develop a symptomatic; RT-PCR or rapid antigen test confirmed SARS-CoV-2 infection. [ Time Frame: Day 1 through Day 14 ]

Proportion of participants who have a negative reverse transcription polymerase chain reaction (RT-PCR) result at baseline who develop a symptomatic; RT-PCR or rapid antigen test confirmed SARS-CoV-2 infection. [ Time Frame: Day 1 through Day 14 ]

Of the participants who have a negative RT-PCR result at baseline; Proportion of participants who develop a symptomatic; RT-PCR confirmed SARS-CoV-2 infection through Day 14.

Of the participants who have a negative RT-PCR result at baseline; Proportion of participants who develop a symptomatic; RT-PCR confirmed SARS-CoV-2 infection through Day 14.